These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6110383)

  • 1. Evaluation of the bronchodilating and antiallergic properties of a beta-adrenoceptor stimulant, KWD 2131, in asthmatic patients.
    Pegelow KO; Strandberg K
    Allergy; 1980 Sep; 35(6):509-19. PubMed ID: 6110383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New beta-agonist, KWD 2131, compared with terbutaline in asthmatics. A cumulative dose-response study.
    Hegardt B; Löwhagen O; Svedmyr N
    Allergy; 1980 Mar; 35(2):105-12. PubMed ID: 6104451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The protective property of equipotent bronchodilating doses of inhaled KWD 2131 and terbutaline against allergen-induced bronchospasm.
    Hegardt B; Löwhagen O; Svedmyr N; Granerus G
    Allergy; 1982 Aug; 37(6):407-16. PubMed ID: 7137535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the inhibition of allergen-induced intracutaneous reactions by a new beta-agonist, KWD 2131, and by terbutaline.
    Hegardt B; Arner B
    Eur J Respir Dis; 1981 Oct; 62(5):352-9. PubMed ID: 6124440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histamine-induced bronchospasm. Its reproducibility and usage in clinical evaluation of the sub-threshold bronchodilating dose of a new beta-agonist, KWD 2131.
    Hegardt B; Löwhagen O; Svedmyr N
    Allergy; 1980 Mar; 35(2):113-21. PubMed ID: 6104452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of KWD 2131, terbutaline, and DSCG on the immediate and late allergen-induced bronchoconstriction.
    Hegardt B; Pauwels R; Van Der Straeten M
    Allergy; 1981 Feb; 36(2):115-22. PubMed ID: 6112931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-anaphylactic and bronchodilating action of a beta-adrenoceptor stimulator, KWD 2131, in human lung tissue.
    Strandberg K; Pegelow KO; Persson CG; Sörenby L
    Allergy; 1979 Aug; 34(4):221-4. PubMed ID: 92896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of intravenous ibuterol (KWD 2058), a new bronchodilator, and terbutaline.
    Larsson S; Svedmyr N
    Eur J Clin Pharmacol; 1977 Jul; 11(6):429-33. PubMed ID: 891586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the protective effect of a new beta-agonist, KWD 2131, on allergen-induced bronchospasm.
    Hegardt B; Löwhagen O; Svedmyr N
    Allergy; 1980 Jul; 35(5):413-9. PubMed ID: 6108726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of a beta-adrenoceptor stimulant, KWD 2131, in nasal histamine provocation tests. Rhinomanometric evaluations in normal persons and patients with hay fever.
    Svensson G; Hegardt B; Löfkvist T
    Acta Otolaryngol; 1981; 92(5-6):535-41. PubMed ID: 6171989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous responses to allergen after local pretreatment with beta-adrenoceptor stimulating and blocking agents.
    Grönneberg R; Strandberg K; Hägermark O
    Allergy; 1980 Jul; 35(5):409-12. PubMed ID: 6108725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pafenolol, a highly selective beta 1-adrenoceptor-antagonist, in asthmatic patients: interaction with terbutaline.
    Löfdahl CG; Marlin GE; Svedmyr N
    Clin Pharmacol Ther; 1983 Jan; 33(1):1-9. PubMed ID: 6129091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic modulation of bronchial hyperreactivity.
    Lowhagen O
    Eur J Respir Dis Suppl; 1982; 117():97-120. PubMed ID: 6807704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between ibuterol hydrochloride and terbutaline in asthma.
    Arner B; Magnusson PO
    Br Med J; 1976 Jan; 1(6001):72-4. PubMed ID: 1106810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic equivalence between bambuterol, 10 mg once daily, and terbutaline controlled release, 5 mg twice daily, in mild to moderate asthma.
    Fugleholm AM; Ibsen TB; Laxmyr L; Svendsen UG
    Eur Respir J; 1993 Nov; 6(10):1474-8. PubMed ID: 8112441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of immediate- and late-response inhibition of a new beta-agonist, KWD 2131, compared with terbutaline and DSCG.
    Hegardt B; Pauwels R; Van der Straeten M
    Int Arch Allergy Appl Immunol; 1981; 66 Suppl 1():283-5. PubMed ID: 6796524
    [No Abstract]   [Full Text] [Related]  

  • 17. Two new beta 2-adrenoceptor agonists, D-2343 and QH 25, studied in asthmatic patients.
    Löfdahl CG; Bengtsson B; Svedmyr K; Svedmyr N
    Allergy; 1982 Jul; 37(5):351-7. PubMed ID: 6127039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies using KWD 2058, a derivative of terbutaline in isolated atrial and tracheal preparations from the guinea-pig.
    Bohmer K; Raper C
    Arch Int Pharmacodyn Ther; 1976 May; 221(1):32-9. PubMed ID: 962428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procaterol and terbutaline in bronchial asthma. A double-blind, placebo-controlled, cross-over study.
    Dahl R; Harving H; Henriksen J; Rønne K; Schøler P
    Allergy; 1985 Oct; 40(7):501-5. PubMed ID: 2933998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of regular terbutaline on the airway response to inhaled budesonide.
    Wilding PJ; Clark MM; Oborne J; Bennett JA; Tattersfield AE
    Thorax; 1996 Oct; 51(10):989-92. PubMed ID: 8977598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.